2019
DOI: 10.1177/2325967119891435
|View full text |Cite
|
Sign up to set email alerts
|

Use of Allografts in Orthopaedic Surgery: Safety, Procurement, Storage, and Outcomes

Abstract: The use of allografts has become a vital option for orthopaedic surgeons in the treatment of a variety of musculoskeletal lesions, ranging from osteochondral defects in the glenohumeral joint to meniscal deficiency in the young athlete. Nevertheless, barriers to treating a patient with an allograft-based procedure may arise from concerns over disease transmission, the navigation of tissue banks that supply allografts, the process of obtaining insurance approval, or optimal storage methods. This review serves t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
31
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(32 citation statements)
references
References 61 publications
0
31
0
1
Order By: Relevance
“…When chondrocytes remain viable during storage, they maintain matrix integrity and, so, the graft properties. 8 Besides, long-term allograft transplant survival depends on graft chondrocyte viability, on matrix maintenance, and on the graft incorporation to host bone. 8,[22][23][24] 4 presents the advantages, disadvantages, and risks of the described technique.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…When chondrocytes remain viable during storage, they maintain matrix integrity and, so, the graft properties. 8 Besides, long-term allograft transplant survival depends on graft chondrocyte viability, on matrix maintenance, and on the graft incorporation to host bone. 8,[22][23][24] 4 presents the advantages, disadvantages, and risks of the described technique.…”
Section: Discussionmentioning
confidence: 99%
“…8 Besides, long-term allograft transplant survival depends on graft chondrocyte viability, on matrix maintenance, and on the graft incorporation to host bone. 8,[22][23][24] 4 presents the advantages, disadvantages, and risks of the described technique. On the basis of this report, as described in this protocol, after adequate harvesting, transport, and storage, fresh humeral head osteochondral allograft is an adequate option for the treatment of patients with massive proximal humeral chondral lesions.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A kiterjedt, illetve mély fokális defektusok biológiai kezelésére, a károsodás területén üvegporc minőségű felszín kialakítására az eddigi irodalmi tapasztalatok alapján a homológ porc-csont szöveti transzplantáció, osteochondralis allograft beültetése ad lehetőséget. Az eddigi, zömmel észak-amerikai gyakorlat szövetbanki úton biztosított, 10 napos és 3 hetes kor közötti kivételből származó osteochondralis allograft blokkokat használ [2]. Bár a masszív osteochondralis defektusok kezelésében az említett eljárás kizárólagos biológiai megoldásnak számít, a megfigyelések azt mutatják, hogy az ilyen módon átültetett osteochondralis allograftok hialinporcsejtjei a donáció és a beültetés közt eltelt idő hosszúsága miatt optimális esetben is csak 50%-os túlélést mutatnak [3].…”
Section: Ultrafriss Osteochondralis Allograft Unikompartmentális Károunclassified
“…To evaluate the capacity for T-LE Allografts to retain metabolic activity in the presence of a fixation method, an in vitro model was developed to monitor graft tissue outgrowth and metabolism over several time points. First, thin layers of TISSEEL (Baxter, Deerfield, IL, USA) fibrin glue, a standard method of graft fixation in a clinical setting (Supplementary Figure 1A), were placed on the bottoms of a 24-well culture plate followed by promptly placing the tissue graft on the TISSEEL surface and culturing for several week intervals [19]. T-LE Allografts cryopreserved for 2 years at − 80°C and fresh noncryopreserved T-LE Allografts 14 days post date of death (stored at 4°C in media) were utilized to report cellular outgrowth from the graft into the TISSEEL layer in vitro.…”
Section: In Vitro Fixation Outgrowth Assay and Metabolic Testingmentioning
confidence: 99%